BioXcel Therapeutics, Inc. - Common Stock (NQ: BTAI )
2.245
-0.185
(-7.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
All News about BioXcel Therapeutics, Inc. - Common Stock


BioXcel Therapeutics's Earnings Outlook
March 11, 2024
Via Benzinga




12 Health Care Stocks Moving In Tuesday's After-Market Session
February 27, 2024
Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session
February 14, 2024
Via Benzinga

Via Get News



12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session
February 12, 2024
Via Benzinga


12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via Benzinga


12 Health Care Stocks Moving In Friday's Intraday Session
February 09, 2024
Via Benzinga


S&P 500 Tops 5,000; PepsiCo Posts Upbeat Earnings
February 09, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities


12 Health Care Stocks Moving In Friday's Pre-Market Session
February 09, 2024
Via Benzinga



12 Health Care Stocks Moving In Thursday's After-Market Session
February 08, 2024
Via Benzinga



Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
Via Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence

Unlocking AI investment opportunities in healthcare
November 16, 2023
Via MarketBeat
Exposures
Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free